Australia's most trusted
source of pharma news
Sunday, 29 September 2024
Posted 24 June 2024 PM
Australian leaders across industry are on the move, taking up new roles - both global and local - in the latest round of job moves.
Big changes at MSD with Michel Jean, Head of Oncology Australia, promoted to AVP of Global Market Access at Merck in the US while Paul Hester, who currently leads the Pharma & Vaccines business across ANZ, will replace Jean as the oncology head.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.